← Eichor
Study identifier: NCT05985629 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

IPACK on Early Pain Scores After ACL Reconstruction

Condition: Pain, Postoperative · Anterior Cruciate Ligament Injuries · Analgesics, Opioid  ·  Sponsor: Loyola University

PhasePhase 4
Planned participants78
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn whether using an anesthetic technique called IPACK block will control pain after ACL reconstruction surgery. The main questions it aims to answer are: * if participants who receive the IPACK block prior to ACL reconstruction experience less pain after surgery and at 1 day after surgery * if participants who receive the IPACK block prior to ACL reconstruction require less short-term opioid use immediately after surgery and up to one week after surgery. Participants will be randomized 1:1 to 1 of 2 groups: Use of IPACK block during ACL reconstruction vs. placebo (a placebo is a look-alike substance that contains no active drug). Neither the participant nor the investigator will know which group the participants has been assigned to. Researchers will compare self-reported pain scores and short-term opioid use of all study participants.

This description comes directly from the study's public registry record.

Talk to the study team

John Miller, MD  ·  708-216-8730  ·  johnmiller@lumc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Loyola University Medical CenterMaywood, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05985629